| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.86 Billion | USD 5.25 Billion | 6.4% | 2024 |
FrequentlyAsked Questions
The global clinical trial supplies market is expected to grow due to rising prevalence of chronic diseases, increasing clinical research activities, growing demand for biologics and personalized medicine, and advancements in cold chain logistics and supply chain management.
According to a study, the global clinical trial supplies market size was worth around USD 2.86 Billion in 2024 and is expected to reach USD 5.25 Billion by 2034.
The global clinical trial supplies market is expected to grow at a CAGR of 6.4% during the forecast period.
North America is expected to dominate the clinical trial supplies market over the forecast period.
Leading players in the global clinical trial supplies market include Thermo Fisher (US), Catalent Inc (US), Parexel (US), Eurofins (France) UDG Healthcare (Ireland), Piramal Pharma Solutions (India), Almac Group (UK), PCI Pharma Services (US), PRA Health Sciences (US), Biocair (UK), Eurofins (France), Marken (US), Infosys (India), Liveo Research (India), Capsugel (a Lonza Group company) (Switzerland), SIRO Clinpharm (India), KLIFO A/S (Denmark), Clinigen (UK), Ancillare (US), N-SIDE (Belgium), ADAllen (UK), Rubicon (India), Durbin (UK), Recipharm (Sweden), Seveillar (India), Myonex (India),, among others.
The report explores crucial aspects of the clinical trial supplies market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients